Questions about the cost-effectiveness of antipneumococcal vaccination;El dilema sobre el coste-efectividad de la vacuna antineumocócica sigue abierto

MEDIFAM - Revista de Medicina Familiar y Comunitaria

Volumn 11, Issue 3, 2001, Pages 115-121

  Alvarez M J ^a   Mayer, M A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G; PNEUMOCOCCUS VACCINE;

COST EFFECTIVENESS ANALYSIS; EDITORIAL; INCIDENCE; META ANALYSIS; MORTALITY; PENICILLIN RESISTANCE; PNEUMONIA; STREPTOCOCCUS INFECTION; VACCINATION;

EID: 0035051329     PISSN: 11315768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (15)

1. The pneumococcal problem
2. Prevención de las enfermedades transmisibles
3. Perspectivas para la vacunación antineumocócica de las personas de edad avanzada en España
4. Hospitalizaciones por neumonía en un hospital general
5. Cost-effectiveness of pneumococcal vaccination of older people study in 5 western european countries
6. Vaccination against pneumococcal disease: Current questions and future opportunities
7. Pneumococcal vaccination in the United States and 20 other developed countries, 1981-1996
8. Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials
9. Efficacy of Pneumococcal Vaccination in Adults. A meta-analysis of randomized controlled trials
10. Clinical effectiveness of pneumococcal vaccine. Meta-analysis
11. Should patients positive for HIV infection receive pneumococcal vaccine?
12. The pneumococcal vaccine after 15 years of use
13. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents
14. Pneumococcal outbreaks in nursing homes
15. Evaluations economiques de la vaccination pneumococcique